Search

Author/Creator Baars, Arnold

1. A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy. (January 2019)

Authors:
Henricks, Linda M.; Lunenburg, Carin A.T.C.; de Man, Femke M.; Meulendijks, Didier; Frederix, Geert W.J.; Kienhuis, Emma; Creemers, Geert-Jan; Baars, Arnold; Dezentjé, Vincent O.; Imholz, Alexander L.T.; Jeurissen, Frank J.F.; Portielje, Johanna E.A.; Jansen, Rob L.H.; Hamberg, Paul; ten Tije, Al...
Journal:
European journal of cancer
Issue:
Volume 107(2019)
Page Start:
60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis. Issue 11 (November 2018)

Authors:
Henricks, Linda M; Lunenburg, Carin A T C; de Man, Femke M; Meulendijks, Didier; Frederix, Geert W J; Kienhuis, Emma; Creemers, Geert-Jan; Baars, Arnold; Dezentjé, Vincent O; Imholz, Alexander L T; Jeurissen, Frank J F; Portielje, Johanna E A; Jansen, Rob L H; Hamberg, Paul; ten Tije, Albert J; D...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 11(2018)
Page Start:
1459
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search